This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Grez, M Articles by Ziegler, M Search for Related Content PubMed PubMed Citation Articles by Grez, M Articles by Ziegler, M

 Previous Article  |  Next Article 

J Virol. 1991 September; 65(9): 4691-4698

A single point mutation activates the Moloney murine leukemia virus long terminal repeat in embryonal stem cells.

Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie, Universität Hamburg, Germany.

ABSTRACT

The expression of Moloney murine leukemia virus (Mo-MuLV) and Mo-MuLV-derived vectors is restricted in undifferentiated mouse embryonal carcinoma and embryonal stem (ES) cells. We have previously described the isolation of retroviral mutants with host range properties expanded to embryonal cell lines. One of these mutants, the murine embryonic stem cell virus (MESV), is expressed in ES cell lines. Expression of MESV in these cells relies on DNA sequence motifs within the enhancer region of the viral long terminal repeat (LTR). Here we show that replacement of the Mo-MuLV enhancer region by sequences derived from the MESV LTR results in the activation of the Mo-MuLV LTR in ES cells. The enhancer regions of MESV and Mo-MuLV differ by seven point mutations. Of these, a single point mutation at position -166 is sufficient to activate the Mo-MuLV LTR and to confer enhancer-dependent expression to Mo-MuLV-derived retroviral vectors in ES cells. This point mutation creates a recognition site for a sequence-specific DNA-binding factor present in nuclear extracts of ES cells. This factor was found by functional assays to be the murine equivalent to human Sp1.

This article has been cited by other articles:

• Ferris, M. T., Joyce, P., Burch, C. L. (2007). High Frequency of Mutations That Expand the Host Range of an RNA Virus. Genetics 176: 1013-1022 [Abstract] [Full Text]  
• Kraunus, J., Zychlinski, D., Heise, T., Galla, M., Bohne, J., Baum, C. (2006). Murine Leukemia Virus Regulates Alternative Splicing through Sequences Upstream of the 5{middle dot} Splice Site. J. Biol. Chem. 281: 37381-37390 [Abstract] [Full Text]  
• van Opijnen, T., Boerlijst, M. C., Berkhout, B. (2006). Effects of random mutations in the human immunodeficiency virus type 1 transcriptional promoter on viral fitness in different host cell environments.. J. Virol. 80: 6678-6685 [Abstract] [Full Text]  
• Haas, D. L., Lutzko, C., Logan, A. C., Cho, G. J., Skelton, D., Jin Yu, X., Pepper, K. A., Kohn, D. B. (2003). The Moloney Murine Leukemia Virus Repressor Binding Site Represses Expression in Murine and Human Hematopoietic Stem Cells. J. Virol. 77: 9439-9450 [Abstract] [Full Text]  
• De Miguel, M. P., Donovan, P. J. (2003). Determinants of Retroviral-Mediated Gene Delivery to Mouse Spermatogonia. Biol. Reprod. 68: 860-866 [Abstract] [Full Text]  
• Wahlers, A., Zipfel, P. F., Schwieger, M., Ostertag, W., Baum, C. (2002). In Vivo Analysis of Retroviral Enhancer Mutations in Hematopoietic Cells: SP1/EGR1 and ETS/GATA Motifs Contribute to Long Terminal Repeat Specificity. J. Virol. 76: 303-312 [Abstract] [Full Text]  
• Hamaguchi, I., Woods, N.-B., Panagopoulos, I., Andersson, E., Mikkola, H., Fahlman, C., Zufferey, R., Carlsson, L., Trono, D., Karlsson, S. (2000). Lentivirus Vector Gene Expression during ES Cell-Derived Hematopoietic Development In Vitro. J. Virol. 74: 10778-10784 [Abstract] [Full Text]  
• Jeeninga, R. E., Hoogenkamp, M., Armand-Ugon, M., de Baar, M., Verhoef, K., Berkhout, B. (2000). Functional Differences between the Long Terminal Repeat Transcriptional Promoters of Human Immunodeficiency Virus Type 1 Subtypes A through G. J. Virol. 74: 3740-3751 [Abstract] [Full Text]  
• Romano, G., Micheli, P., Pacilio, C., Giordano, A. (2000). Latest Developments in Gene Transfer Technology: Achievements, Perspectives, and Controversies over Therapeutic Applications. Stem Cells 18: 19-39 [Abstract] [Full Text]  
• Williams, D. A., Nienhuis, A. W., Hawley, R. G., Smith, F. O. (2000). Gene Therapy 2000. ASH Education Book 2000: 376-393 [Abstract] [Full Text]  
• Berkhout, B., Verhoef, K., van Wamel, J. L. B., Back, N. K. T. (1999). Genetic Instability of Live, Attenuated Human Immunodeficiency Virus Type 1 Vaccine Strains. J. Virol. 73: 1138-1145 [Abstract] [Full Text]  
• Hauses, M., Tonjes, R. R., Grez, M. (1998). The Transcription Factor Sp1 Regulates the Myeloid-specific Expression of the Human Hematopoietic Cell Kinase (HCK) Gene through Binding to Two Adjacent GC Boxes within the HCK Promoter-Proximal Region. J. Biol. Chem. 273: 31844-31852 [Abstract] [Full Text]  
• Robbins, P. B., Skelton, D. C., Yu, X.-J., Halene, S., Leonard, E. H., Kohn, D. B. (1998). Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 95: 10182-10187 [Abstract] [Full Text]  
• Laker, C., Meyer, J., Schopen, A., Friel, J., Heberlein, C., Ostertag, W., Stocking, C. (1998). Host cis-Mediated Extinction of a Retrovirus Permissive for Expression in Embryonal Stem Cells during Differentiation. J. Virol. 72: 339-348 [Abstract] [Full Text]  
• Munk, C., Lohler, J., Prassolov, V., Just, U., Stockschlader, M., Stocking, C. (1997). Amphotropic murine leukemia viruses induce spongiform encephalomyelopathy. Proc. Natl. Acad. Sci. USA 94: 5837-5842 [Abstract] [Full Text]